BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 12196890)

  • 1. Paraneoplastic pemphigus: a refractory autoimmune mucocutaneous disease.
    Ng PP; Rencic A; Nousari HC
    J Cutan Med Surg; 2002; 6(5):434-7. PubMed ID: 12196890
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Current management strategies in paraneoplastic pemphigus (paraneoplastic autoimmune multiorgan syndrome).
    Frew JW; Murrell DF
    Dermatol Clin; 2011 Oct; 29(4):607-12. PubMed ID: 21925005
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Follicular non-Hodgkin's lymphoma with refractory paraneoplastic pemphigus: case report with review of novel treatment modalities.
    Rossum MM; Verhaegen NT; Jonkman MF; Mackenzie MA; Koster A; Van Der Valk PG; Span LF
    Leuk Lymphoma; 2004 Nov; 45(11):2327-32. PubMed ID: 15512825
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of mycophenolate mofetil in the treatment of paraneoplastic pemphigus.
    Williams JV; Marks JG; Billingsley EM
    Br J Dermatol; 2000 Mar; 142(3):506-8. PubMed ID: 10735959
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Paraneoplastic pemphigus in a patient with non-Hodgkin's lymphoma.
    Plumb R; Doolittle GC
    Am J Hematol; 1996 May; 52(1):58-9. PubMed ID: 8638613
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Successful treatment with mycophenolate mofetil of four Japanese patients with pemphigus vulgaris.
    Koga H; Ishii N; Hamada T; Karashima T; Nakama T; Yasumoto S; Hashimoto T
    Eur J Dermatol; 2010; 20(4):472-5. PubMed ID: 20406724
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Paraneoplastic pemphigus occurring in a patient with B-cell non-Hodgkin's lymphoma.
    Schlesinger T; McCarron K; Camisa C; Anhalt G
    Cutis; 1998 Feb; 61(2):94-6. PubMed ID: 9515216
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Paraneoplastic pemphigus: a case report and review of literature.
    Tilakaratne W; Dissanayake M
    Oral Dis; 2005 Sep; 11(5):326-9. PubMed ID: 16120122
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Paraneoplastic pemphigus triggered by radiotherapy.
    Lee MS; Kossard S; Ho KK; Barnetson RS; Ravich RB
    Australas J Dermatol; 1995 Nov; 36(4):206-10. PubMed ID: 8593111
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Paraneoplastic pemphigus: a clinical, laboratorial, and therapeutic overview.
    Maruta CW; Miyamoto D; Aoki V; Carvalho RGR; Cunha BM; Santi CG
    An Bras Dermatol; 2019; 94(4):388-398. PubMed ID: 31644609
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An evaluation of the usefulness of mycophenolate mofetil in pemphigus.
    Powell AM; Albert S; Al Fares S; Harman KE; Setterfield J; Bhogal B; Black MM
    Br J Dermatol; 2003 Jul; 149(1):138-45. PubMed ID: 12890207
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Successful treatment of B cell chronic lymphocytic leukemia-associated severe paraneoplastic pemphigus with cyclosporin A.
    Gergely L; Váróczy L; Vadász G; Remenyik E; Illés A
    Acta Haematol; 2003; 109(4):202-5. PubMed ID: 12853695
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunoablative high-dose cyclophosphamide without stem cell rescue in paraneoplastic pemphigus: report of a case and review of this new therapy for severe autoimmune disease.
    Nousari HC; Brodsky RA; Jones RJ; Grever MR; Anhalt GJ
    J Am Acad Dermatol; 1999 May; 40(5 Pt 1):750-4. PubMed ID: 10321604
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Paraneoplastic pemphigus: Retrospective study of a case series].
    Fournet M; Roblot P; P Levillain ; Guillet G; Machet L; Misery L
    Ann Dermatol Venereol; 2018 Oct; 145(10):564-571. PubMed ID: 30126641
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Paraneoplastic pemphigus occuring after radiotherapy for relapsed non-Hodgkin's lymphoma in a patient with common variable immunodeficiency.
    Stark GL; Goff DK; Spickett GP; Wojnarowska F; Langtry JA
    Hematol J; 2003; 4(2):154-8. PubMed ID: 12750736
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Paraneoplastic pemphigus associated with non-Hodgkin lymphoma.
    Batista MD; Takano D; Lopes RD; Enokihara MM; Michalany NS; de Almeida FA
    Dermatol Online J; 2008 Jun; 14(6):11. PubMed ID: 18713592
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of pemphigus vulgaris: current and emerging options.
    Yeh SW; Sami N; Ahmed RA
    Am J Clin Dermatol; 2005; 6(5):327-42. PubMed ID: 16252932
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Paraneoplastic pemphigus associated with Castleman tumor, myasthenia gravis and bronchiolitis obliterans.
    Chorzelski T; Hashimoto T; Maciejewska B; Amagai M; Anhalt GJ; Jablonska S
    J Am Acad Dermatol; 1999 Sep; 41(3 Pt 1):393-400. PubMed ID: 10459112
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Paraneoplastic pemphigus associated with CD20-positive follicular non-Hodgkin's lymphoma treated with rituximab: a third case resistant to rituximab therapy.
    Hoque SR; Black MM; Cliff S
    Clin Exp Dermatol; 2007 Mar; 32(2):172-5. PubMed ID: 17342796
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Paraneoplastic pemphigus associated with non-Hodgkin's lymphoma.
    Ishigami T; Kubo Y; Matsudate Y; Ansai S; Arase S; Ohyama B; Hashimoto T
    Eur J Dermatol; 2011; 21(1):122-4. PubMed ID: 21190909
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.